Hikal slips 21% in one week, hits fresh 52-week low on disappointing Q4

The inflationary pressures and a sharp rise in input costs of raw material, energy and solvents, the management expects industry growth to be tapered and margins to be contract in the current fiscal.

Shares of Hikal hit a fresh 52-week low of Rs 303.50, down 4 per cent on the BSE in Friday’s trade. The stock of the company has fallen 21 per cent in the last one week after the firm reported a weak set of numbers for the quarter ended March 2022 (Q4FY22). In comparison, at 01:50 pm, the S&P BSE Sensex was up 0.5 per cent at 56,090 points. 

With the past one week's decline, the stock of the pharmaceutical company has corrected 59 per cent from its record high level of Rs 742 touched on August 17, 2021.